top_10_image_2_9

Pharmafile.com’s top 10 news stories of the week

pharmafile | May 28, 2021 | News story | Medical Communications  

Among our ten most-read stories this week: a French study has found that dogs can detect COVID-19 with 97% accuracy, the first COVID-fighting herbal supplement has been launched, and new research has begun to produce HIV treatments in plants.

 1. Dogs can detect COVID-19 with 97% accuracy, study finds – Published 21/05/21

A French trial has found has found that dogs are able to detect COVID-19 with 97% accuracy in humans, which means they are more effective than lateral flow tests.

 2. First COVID-fighting herbal supplement launched – Published 27/05/21

The first herbal supplement shown in clinical trials to prevent COVID-19 symptoms from deteriorating has been launched by Swiss Pharmacan AG.

 3. NICE rejects Janssen’s prostate cancer drug Erleada – Published 21/05/21

NICE has published has published draft guidance rejecting Janssen’s Erleada (apalutamide) with androgen deprivation therapy (ADT) for treating prostate cancer.

 4.  New research begins on producing HIV treatments in plants – Published 25/05/21

St George’s, University of London has announced a partnership with Leaf Expression Systems to produce HIV treatments in plants.

 5. Doctor vigilance urged for rare instances of stroke following COVID-19 vaccinations – Published 26/05/21

Doctors have been urged to be vigilant for signs of stroke after three rare instances have occurred in Oxford-AstraZeneca patients.

 6. Vaccines highly effective against Indian variant, study showsPublished 24/05/21

A new Public Health England (PHE) study shows that two doses of either the Pfizer-BioNTech or the Oxford-AstraZeneca vaccine are highly effective against the B.1.617.2 (Indian) variant.

 7. Sanofi-GSK Phase III trial begins for COVID-19 vaccinePublished 27/05/21

Sanofi and GSK have begun their Phase III clinical study to assess the safety, efficacy, and immunogenicity of their COVID-19 vaccine today.

 8. FDA grants accelerated approval for Janssen’s lung cancer drugPublished 24/05/21

The FDA have granted accelerated approval of Rybrevant (amivantamab-vmjw) for the treatment of patients with metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 20 insertion mutations, whose disease has progressed on or after platinum-based chemotherapy.

 9. Medical cannabis more effective painkiller in 86% of chronic pain patientsPublished 27/05/21

The Medical Cannabis Clinics (TMCC) have released new data from a survey of patients prescribed medical cannabis to treat pain, in which 86% reported medical cannabis to be more effective than other medication they had previously taken.

 10. CMA to review AstraZeneca’s $39 billion buyout of AlexionPublished 25/05/21

The UK’s Competition and Markets Authority (CMA) is to review AstraZeneca’s $39 billion buyout of US-based Alexion Pharmaceuticals.

Related Content

No items found

Latest content